Follistim AQ Cartridge (follitropin beta)
/ Organon
- LARVOL DELTA
Home
Next
Prev
1 to 20
Of
20
Go to page
1
March 18, 2025
HEART: Hormone Evaluation in Artificial Reproductive Technology
(clinicaltrials.gov)
- P=N/A | N=810 | Completed | Sponsor: Lund University | Phase classification: P4 ➔ P=N/A | Trial completion date: Jun 2024 ➔ Oct 2024
Phase classification • Trial completion date • Gynecology • Infertility • Sexual Disorders
October 01, 2024
Follitropin Alpha versus Follitropin Beta in IVF/ICSI Cycle: A Retrospective Cohort Study.
(PubMed, Drug Des Devel Ther)
- "Furthermore, Puregon can eliminate unneeded anxiety and expenses while also administering more flexibility. Taken together, these findings could well be utilized in everyday clinical practice to better inform patients when deciding on an ovarian stimulation strategy."
Clinical • Journal • Retrospective data • Gynecology • Infertility • Mood Disorders • Psychiatry
July 17, 2024
Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells
(clinicaltrials.gov)
- P1 | N=6 | Completed | Sponsor: ART Fertility Clinics LLC | Recruiting ➔ Completed | N=10 ➔ 6 | Trial completion date: Jan 2024 ➔ Jun 2024 | Trial primary completion date: Dec 2023 ➔ Mar 2024
Enrollment change • Trial completion • Trial completion date • Trial primary completion date • Gynecology • Infertility • Sexual Disorders
July 03, 2024
HEART: Hormone Evaluation in Artificial Reproductive Technology
(clinicaltrials.gov)
- P4 | N=796 | Completed | Sponsor: Lund University | Trial completion date: Dec 2020 ➔ May 2024
Adverse events • Biomarker • Trial completion date • Gynecology • Infertility • Sexual Disorders
June 03, 2024
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
(clinicaltrials.gov)
- P4 | N=60 | Not yet recruiting | Sponsor: University Hospital, Ghent | Initiation date: Apr 2024 ➔ Jul 2024
Trial initiation date
March 05, 2024
Comparison of DNA damage in granulosa cells of women undergoing controlled ovarian stimulation in in vitro fertilization protocols with the recombinant human follicle-stimulating hormones Corneumon®, Gonal-F®, Pergoveris® and Puregon®: a randomized trial.
(PubMed, Arch Gynecol Obstet)
- "Use of Corneumon® and Pergoveris® in COS caused statistically significantly lower levels of DNA damage in GCs of infertile women undergoing ART, which could potentially correlate with better reproductive outcomes."
Journal • Preclinical • Gynecology • Infertility • Sexual Disorders
January 17, 2024
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
(clinicaltrials.gov)
- P4 | N=60 | Not yet recruiting | Sponsor: University Hospital, Ghent | Initiation date: Jan 2024 ➔ Apr 2024
Trial initiation date
January 05, 2024
TROPIX: Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)
(clinicaltrials.gov)
- P=N/A | N=318 | Not yet recruiting | Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
New trial • Infertility • Sexual Disorders
December 19, 2023
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
(clinicaltrials.gov)
- P4 | N=60 | Not yet recruiting | Sponsor: University Hospital, Ghent
New P4 trial
December 13, 2023
2-Shot: Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.
(clinicaltrials.gov)
- P3 | N=194 | Recruiting | Sponsor: Fundación Santiago Dexeus Font | Not yet recruiting ➔ Recruiting
Enrollment open • Trial completion date • Trial primary completion date
October 06, 2023
ELONVA FLARE PROTOCOL: a new approach for poor responders in superovulation for In Vitro Fertilisation (IVF).
(ANZCTR)
- P1 | N=20 | Completed | Sponsor: UNSW | Not yet recruiting ➔ Completed
Trial completion • Gynecology • Infertility • Sexual Disorders
July 12, 2023
Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells
(clinicaltrials.gov)
- P1 | N=10 | Recruiting | Sponsor: ART Fertility Clinics LLC | Not yet recruiting ➔ Recruiting | Trial completion date: Aug 2023 ➔ Jan 2024 | Trial primary completion date: Jul 2023 ➔ Dec 2023
Enrollment open • Trial completion date • Trial primary completion date • Gynecology • Infertility • Sexual Disorders
June 01, 2023
Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity
(clinicaltrials.gov)
- P4 | N=24 | Completed | Sponsor: Instituto Valenciano de Infertilidade de Lisboa | Active, not recruiting ➔ Completed
Trial completion • Gynecology • Infertility • Sexual Disorders
April 12, 2023
Tailored Ovarian Stimulation Based on BMI, AMH, AFC
(clinicaltrials.gov)
- P4 | N=300 | Recruiting | Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Trial completion date: Jun 2021 ➔ Dec 2023 | Trial primary completion date: Jun 2021 ➔ Dec 2023
Trial completion date • Trial primary completion date • Infertility • Sexual Disorders
March 09, 2023
Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity
(clinicaltrials.gov)
- P4 | N=24 | Active, not recruiting | Sponsor: Instituto Valenciano de Infertilidade de Lisboa | Recruiting ➔ Active, not recruiting | Trial completion date: Dec 2022 ➔ May 2023 | Trial primary completion date: Dec 2022 ➔ May 2023
Enrollment closed • Trial completion date • Trial primary completion date • Gynecology • Infertility • Sexual Disorders
February 02, 2023
Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: ART Fertility Clinics LLC | Trial completion date: Nov 2022 ➔ Aug 2023 | Initiation date: Aug 2022 ➔ Mar 2023 | Trial primary completion date: Oct 2022 ➔ Jul 2023
Trial completion date • Trial initiation date • Trial primary completion date • Gynecology • Infertility • Sexual Disorders
June 30, 2022
Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: ART Fertility Clinics LLC | Initiation date: May 2022 ➔ Aug 2022
Trial initiation date • Gynecology • Infertility • Sexual Disorders
April 22, 2022
HEART: Hormone Evaluation in Artificial Reproductive Technology
(clinicaltrials.gov)
- P4 | N=796 | Completed | Sponsor: Lund University | Recruiting ➔ Completed
Adverse events • Biomarker • Trial completion • Gynecology • Infertility • Sexual Disorders
April 15, 2022
Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: ART Fertility Clinics LLC
New P1 trial • Gynecology • Infertility • Sexual Disorders
March 29, 2022
Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity
(clinicaltrials.gov)
- P4 | N=30 | Recruiting | Sponsor: Instituto Valenciano de Infertilidade de Lisboa | Trial completion date: Dec 2021 ➔ Dec 2022 | Trial primary completion date: Dec 2021 ➔ Dec 2022
Preclinical • Trial completion date • Trial primary completion date • Gynecology • Infertility • Sexual Disorders
1 to 20
Of
20
Go to page
1